Effect of Fluconazole on the Pharmacokinetics of Pyrotinib in Healthy Subjects
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Healthy Subjects
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: Pyrotinib alone and then combination with fluconazoleMasking: None (Open Label)Primary Purpose: Other
Participation Requirements
- Age
- Between 18 years and 45 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04850651
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon